Capturing  ||| S:0 E:10 ||| VBG
the  ||| S:10 E:14 ||| DT
target  ||| S:14 E:21 ||| NN
genes  ||| S:21 E:27 ||| NNS
of  ||| S:27 E:30 ||| IN
BldD  ||| S:30 E:35 ||| JJ
in  ||| S:35 E:38 ||| IN
Saccharopolyspora  ||| S:38 E:56 ||| NNP
erythraea  ||| S:56 E:66 ||| FW
using  ||| S:66 E:72 ||| FW
improved  ||| S:72 E:81 ||| FW
genomic  ||| S:81 E:89 ||| FW
SELEX  ||| S:89 E:95 ||| FW
method  ||| S:95 E:102 ||| FW
BldD  ||| S:102 E:107 ||| FW
( ||| S:107 E:108 ||| -LRB-
SACE_2077 ||| S:108 E:117 ||| NNP
) ||| S:117 E:118 ||| -RRB-
,  ||| S:118 E:120 ||| ,
a  ||| S:120 E:122 ||| DT
key  ||| S:122 E:126 ||| JJ
developmental  ||| S:126 E:140 ||| JJ
regulator  ||| S:140 E:150 ||| NN
in  ||| S:150 E:153 ||| IN
actinomycetes ||| S:153 E:166 ||| NN
,  ||| S:166 E:168 ||| ,
is  ||| S:168 E:171 ||| VBZ
the  ||| S:171 E:175 ||| DT
first  ||| S:175 E:181 ||| JJ
identified  ||| S:181 E:192 ||| VBN
transcriptional  ||| S:192 E:208 ||| JJ
factor  ||| S:208 E:215 ||| NN
in  ||| S:215 E:218 ||| IN
Saccharopolyspora  ||| S:218 E:236 ||| NNP
erythraea  ||| S:236 E:246 ||| VBD
positively  ||| S:246 E:257 ||| RB
regulating  ||| S:257 E:268 ||| VBG
erythromycin  ||| S:268 E:281 ||| JJ
production  ||| S:281 E:292 ||| NN
and  ||| S:292 E:296 ||| CC
morphological  ||| S:296 E:310 ||| JJ
differentiation ||| S:310 E:325 ||| NN
.  ||| S:325 E:327 ||| .
Although  ||| S:327 E:336 ||| IN
the  ||| S:336 E:340 ||| DT
BldD  ||| S:340 E:345 ||| JJ
of  ||| S:345 E:348 ||| IN
S.  ||| S:348 E:351 ||| NNP
erythraea  ||| S:351 E:361 ||| VBD
binds  ||| S:361 E:367 ||| VBN
to  ||| S:367 E:370 ||| TO
the  ||| S:370 E:374 ||| DT
promoters  ||| S:374 E:384 ||| NNS
of  ||| S:384 E:387 ||| IN
erythromycin  ||| S:387 E:400 ||| JJ
biosynthetic  ||| S:400 E:413 ||| JJ
genes ||| S:413 E:418 ||| NNS
,  ||| S:418 E:420 ||| ,
the  ||| S:420 E:424 ||| DT
interaction  ||| S:424 E:436 ||| JJ
affinities  ||| S:436 E:447 ||| NNS
are  ||| S:447 E:451 ||| VBP
relatively  ||| S:451 E:462 ||| RB
low ||| S:462 E:465 ||| JJ
,  ||| S:465 E:467 ||| ,
implying  ||| S:467 E:476 ||| VBG
the  ||| S:476 E:480 ||| DT
existence  ||| S:480 E:490 ||| NN
of  ||| S:490 E:493 ||| IN
its  ||| S:493 E:497 ||| PRP$
other  ||| S:497 E:503 ||| JJ
target  ||| S:503 E:510 ||| NN
genes  ||| S:510 E:516 ||| NNS
in  ||| S:516 E:519 ||| IN
S.  ||| S:519 E:522 ||| NNP
erythraea ||| S:522 E:531 ||| NN
.  ||| S:531 E:533 ||| .
Through  ||| S:533 E:541 ||| IN
the  ||| S:541 E:545 ||| DT
genomic  ||| S:545 E:553 ||| JJ
systematic  ||| S:553 E:564 ||| JJ
evolution  ||| S:564 E:574 ||| NN
of  ||| S:574 E:577 ||| IN
ligands  ||| S:577 E:585 ||| NN
by  ||| S:585 E:588 ||| IN
exponential  ||| S:588 E:600 ||| JJ
enrichment  ||| S:600 E:611 ||| NNS
( ||| S:611 E:612 ||| -LRB-
SELEX ||| S:612 E:617 ||| NNP
)  ||| S:617 E:619 ||| -RRB-
method  ||| S:619 E:626 ||| NN
that  ||| S:626 E:631 ||| IN
we  ||| S:631 E:634 ||| PRP
herein  ||| S:634 E:641 ||| VBP
improved ||| S:641 E:649 ||| VBN
,  ||| S:649 E:651 ||| ,
four  ||| S:651 E:656 ||| CD
DNA  ||| S:656 E:660 ||| NN
sequences  ||| S:660 E:670 ||| NN
of  ||| S:670 E:673 ||| IN
S.  ||| S:673 E:676 ||| NNP
erythraea  ||| S:676 E:686 ||| VBD
A226 ||| S:686 E:690 ||| CD
,  ||| S:690 E:692 ||| ,
corresponding  ||| S:692 E:706 ||| JJ
to  ||| S:706 E:709 ||| TO
the  ||| S:709 E:713 ||| DT
promoter  ||| S:713 E:722 ||| NN
regions  ||| S:722 E:730 ||| NNS
of  ||| S:730 E:733 ||| IN
SACE_0306  ||| S:733 E:743 ||| NNP
( ||| S:743 E:744 ||| -LRB-
beta-galactosidase ||| S:744 E:762 ||| NNP
) ||| S:762 E:763 ||| -RRB-
,  ||| S:763 E:765 ||| ,
SACE_0811  ||| S:765 E:775 ||| NNP
( ||| S:775 E:776 ||| -LRB-
50S  ||| S:776 E:780 ||| FW
ribosomal  ||| S:780 E:790 ||| FW
protein  ||| S:790 E:798 ||| FW
L25 ||| S:798 E:801 ||| FW
) ||| S:801 E:802 ||| -RRB-
,  ||| S:802 E:804 ||| ,
SACE_3410  ||| S:804 E:814 ||| NNP
( ||| S:814 E:815 ||| -LRB-
fumarylacetoacetate  ||| S:815 E:835 ||| FW
hydrolase ||| S:835 E:844 ||| FW
) ||| S:844 E:845 ||| -RRB-
,  ||| S:845 E:847 ||| ,
and  ||| S:847 E:851 ||| CC
SACE_6014  ||| S:851 E:861 ||| NNP
( ||| S:861 E:862 ||| -LRB-
aldehyde  ||| S:862 E:871 ||| FW
dehydrogenase ||| S:871 E:884 ||| FW
) ||| S:884 E:885 ||| -RRB-
,  ||| S:885 E:887 ||| ,
were  ||| S:887 E:892 ||| VBD
captured  ||| S:892 E:901 ||| VBN
with  ||| S:901 E:906 ||| IN
all  ||| S:906 E:910 ||| DT
three  ||| S:910 E:916 ||| CD
BldD  ||| S:916 E:921 ||| JJ
concentrations  ||| S:921 E:936 ||| NNS
of  ||| S:936 E:939 ||| IN
0.5 ||| S:939 E:942 ||| CD
,  ||| S:942 E:944 ||| ,
1 ||| S:944 E:945 ||| CD
,  ||| S:945 E:947 ||| ,
and  ||| S:947 E:951 ||| CC
2  ||| S:951 E:953 ||| CD
μM ||| S:953 E:955 ||| NN
,  ||| S:955 E:957 ||| ,
while  ||| S:957 E:963 ||| IN
the  ||| S:963 E:967 ||| DT
previously  ||| S:967 E:978 ||| RB
identified  ||| S:978 E:989 ||| VBN
intergenic  ||| S:989 E:1000 ||| JJ
regions  ||| S:1000 E:1008 ||| NNS
of  ||| S:1008 E:1011 ||| IN
eryBIV-eryAI  ||| S:1011 E:1024 ||| JJ
and  ||| S:1024 E:1028 ||| CC
ermE-eryCI  ||| S:1028 E:1039 ||| JJ
plus  ||| S:1039 E:1044 ||| CC
the  ||| S:1044 E:1048 ||| DT
promoter  ||| S:1048 E:1057 ||| NN
region  ||| S:1057 E:1064 ||| NN
of  ||| S:1064 E:1067 ||| IN
SACE_7115 ||| S:1067 E:1076 ||| NNP
,  ||| S:1076 E:1078 ||| ,
the  ||| S:1078 E:1082 ||| DT
amfC  ||| S:1082 E:1087 ||| JJ
homolog  ||| S:1087 E:1095 ||| NN
for  ||| S:1095 E:1099 ||| IN
aerial  ||| S:1099 E:1106 ||| JJ
mycelium  ||| S:1106 E:1115 ||| JJ
formation ||| S:1115 E:1124 ||| NN
,  ||| S:1124 E:1126 ||| ,
could  ||| S:1126 E:1132 ||| MD
be  ||| S:1132 E:1135 ||| VB
captured  ||| S:1135 E:1144 ||| VBN
only  ||| S:1144 E:1149 ||| RB
when  ||| S:1149 E:1154 ||| WRB
the  ||| S:1154 E:1158 ||| DT
BldD ||| S:1158 E:1162 ||| NNP
's  ||| S:1162 E:1165 ||| POS
concentration  ||| S:1165 E:1179 ||| NN
reached  ||| S:1179 E:1187 ||| VBD
2  ||| S:1187 E:1189 ||| CD
μM ||| S:1189 E:1191 ||| NN
.  ||| S:1191 E:1193 ||| .
Electrophoretic  ||| S:1193 E:1209 ||| FW
mobility  ||| S:1209 E:1218 ||| FW
shift  ||| S:1218 E:1224 ||| FW
assay  ||| S:1224 E:1230 ||| FW
( ||| S:1230 E:1231 ||| -LRB-
EMSA ||| S:1231 E:1235 ||| NNP
)  ||| S:1235 E:1237 ||| -RRB-
analysis  ||| S:1237 E:1246 ||| NN
indicated  ||| S:1246 E:1256 ||| VBD
that  ||| S:1256 E:1261 ||| DT
BldD  ||| S:1261 E:1266 ||| JJ
specifically  ||| S:1266 E:1279 ||| RB
bound  ||| S:1279 E:1285 ||| VBN
to  ||| S:1285 E:1288 ||| TO
above  ||| S:1288 E:1294 ||| IN
seven  ||| S:1294 E:1300 ||| CD
DNA  ||| S:1300 E:1304 ||| NN
sequences ||| S:1304 E:1313 ||| NN
,  ||| S:1313 E:1315 ||| ,
and  ||| S:1315 E:1319 ||| CC
quantitative  ||| S:1319 E:1332 ||| JJ
real-time  ||| S:1332 E:1342 ||| JJ
PCR  ||| S:1342 E:1346 ||| NNP
( ||| S:1346 E:1347 ||| -LRB-
qRT-PCR ||| S:1347 E:1354 ||| NNP
)  ||| S:1354 E:1356 ||| -RRB-
assay  ||| S:1356 E:1362 ||| NN
showed  ||| S:1362 E:1369 ||| VBD
that  ||| S:1369 E:1374 ||| IN
the  ||| S:1374 E:1378 ||| DT
transcriptional  ||| S:1378 E:1394 ||| JJ
levels  ||| S:1394 E:1401 ||| NNS
of  ||| S:1401 E:1404 ||| IN
the  ||| S:1404 E:1408 ||| DT
abovementioned  ||| S:1408 E:1423 ||| JJ
target  ||| S:1423 E:1430 ||| NN
genes  ||| S:1430 E:1436 ||| NNS
decreased  ||| S:1436 E:1446 ||| VBD
when  ||| S:1446 E:1451 ||| WRB
bldD  ||| S:1451 E:1456 ||| NNP
was  ||| S:1456 E:1460 ||| VBD
disrupted  ||| S:1460 E:1470 ||| VBN
in  ||| S:1470 E:1473 ||| IN
A226 ||| S:1473 E:1477 ||| CD
.  ||| S:1477 E:1479 ||| .
Furthermore ||| S:1479 E:1490 ||| RB
,  ||| S:1490 E:1492 ||| ,
SACE_7115  ||| S:1492 E:1502 ||| NNP
and  ||| S:1502 E:1506 ||| CC
SACE_0306  ||| S:1506 E:1516 ||| CD
in  ||| S:1516 E:1519 ||| IN
A226  ||| S:1519 E:1524 ||| NNP
were  ||| S:1524 E:1529 ||| VBD
individually  ||| S:1529 E:1542 ||| RB
inactivated ||| S:1542 E:1553 ||| JJ
,  ||| S:1553 E:1555 ||| ,
showing  ||| S:1555 E:1563 ||| VBG
that  ||| S:1563 E:1568 ||| IN
SACE_7115  ||| S:1568 E:1578 ||| NNP
was  ||| S:1578 E:1582 ||| VBD
predominantly  ||| S:1582 E:1596 ||| RB
involved  ||| S:1596 E:1605 ||| VBN
in  ||| S:1605 E:1608 ||| IN
aerial  ||| S:1608 E:1615 ||| JJ
mycelium  ||| S:1615 E:1624 ||| JJ
formation ||| S:1624 E:1633 ||| NN
,  ||| S:1633 E:1635 ||| ,
while  ||| S:1635 E:1641 ||| IN
SACE_0306  ||| S:1641 E:1651 ||| NNP
mainly  ||| S:1651 E:1658 ||| RB
controlled  ||| S:1658 E:1669 ||| VBN
erythromycin  ||| S:1669 E:1682 ||| JJ
production ||| S:1682 E:1692 ||| NN
.  ||| S:1692 E:1694 ||| .
This  ||| S:1694 E:1699 ||| DT
study  ||| S:1699 E:1705 ||| NN
provides  ||| S:1705 E:1714 ||| VBZ
valuable  ||| S:1714 E:1723 ||| JJ
information  ||| S:1723 E:1735 ||| NN
for  ||| S:1735 E:1739 ||| IN
better  ||| S:1739 E:1746 ||| JJR
understanding  ||| S:1746 E:1760 ||| NN
of  ||| S:1760 E:1763 ||| IN
the  ||| S:1763 E:1767 ||| DT
pleiotropic  ||| S:1767 E:1779 ||| JJ
regulator  ||| S:1779 E:1789 ||| NN
BldD  ||| S:1789 E:1794 ||| NN
in  ||| S:1794 E:1797 ||| IN
S.  ||| S:1797 E:1800 ||| NNP
erythraea ||| S:1800 E:1809 ||| NN
,  ||| S:1809 E:1811 ||| ,
and  ||| S:1811 E:1815 ||| CC
the  ||| S:1815 E:1819 ||| DT
improved  ||| S:1819 E:1828 ||| JJ
method  ||| S:1828 E:1835 ||| NN
may  ||| S:1835 E:1839 ||| MD
be  ||| S:1839 E:1842 ||| VB
useful  ||| S:1842 E:1849 ||| JJ
for  ||| S:1849 E:1853 ||| IN
uncovering  ||| S:1853 E:1864 ||| VBG
regulatory  ||| S:1864 E:1875 ||| JJ
networks  ||| S:1875 E:1884 ||| NNS
of  ||| S:1884 E:1887 ||| IN
other  ||| S:1887 E:1893 ||| JJ
transcriptional  ||| S:1893 E:1909 ||| JJ
factors ||| S:1909 E:1916 ||| NNS
.  ||| S:1916 E:1918 ||| .
